Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 8,095 $ 4,102
INVESTING ACTIVITIES    
Purchase of medical equipment and property (4,962) (2,829)
Proceeds from sale of medical equipment and property 2,900 3,518
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (2,062) 689
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (5,048) (35,769)
Cash proceeds from credit facility 9,660 28,317
Debt issuance costs (27) (38)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (5) (27)
Common stock repurchased as part of Repurchase Program (10,291)
Cash proceeds from stock plans 91 131
NET CASH USED IN FINANCING ACTIVITIES (5,620) (7,386)
Net change in cash and cash equivalents 413 (2,595)
Cash and cash equivalents, beginning of period 3,469 3,398
Cash and cash equivalents, end of period $ 3,882 $ 803